GoodRx is great! - Patient Advocate GoodRx Employee Review

5.0
Feb 22, 2018
Recommend
CEO approval
Business Outlook

Pros

GoodRx is an excellent company to work for! Since joining the company (Feb. 2017) the company has grown in an impressive and rapid fashion (and continues to grow)! During my time here, I have had the pleasure of being surrounded by extremely talented and caring people who work hard to better our product, educate our clients, and create exciting new ideas so that we can continue to have sustainable growth. Not to mention, the culture at GoodRx is incredibly professional, positive and fun! I am happy to say that the dreadful feeling of Monday mornings are now a thing of the past. I've found that GoodRx encourages your entrepreneurial spirit and truly values your suggestions. This has not only opened up many opportunities for me within my department but for potential opportunities in other departments as well. I have genuine appreciation for the mission of this company to help patients save the most on their prescriptions! I fully stand behind this brand and I am proud to be an employee of their company.

Cons

I do not have any at this time!

Explore other reviews about GoodRx

5.0
May 14, 2026
Recommend
CEO approval
Business Outlook

Pros

Great space to learn, encouraged learning from mistakes, great overall positive attitude and collaboration amongst eng and non-eng co-workers

Cons

Started to feel more of a company that started prioritizing profits and started to think of several products to ship out without much support for the reason or long term support to improve the products.

1
4.0
Jun 23, 2026
Recommend
CEO approval
Business Outlook

Pros

Great compensation and benefits. Extreme work flexibility. Mission driven work where you know your directly helping Americans access important health care. Company is taking a great measured approach to AI adoption.

Cons

GoodRx is an established dominant player in the prescription drug space and is starting to flounder a bit in the face of stiff, more digital first, competition. Unclear what the future holds and this is reflected in the stock price. As such project direction can be a bit vague. Similarly a long history of tech debt, further muddled by HIPAA requirements, can make product development painful.

See reviews by: Helpful|Rating|Date|All